4//SEC Filing
Kelly Leanne 4
Accession 0001824293-25-000138
CIK 0001824293other
Filed
Aug 26, 8:00 PM ET
Accepted
Aug 27, 8:24 AM ET
Size
5.8 KB
Accession
0001824293-25-000138
Insider Transaction Report
Form 4
Kelly Leanne
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-08-26+11,854→ 11,854 totalExercise: $1.41Exp: 2035-08-26→ Common Stock (11,854 underlying)
Footnotes (1)
- [F1]Options to purchase 7,424 shares vested in full upon the date of grant and options to purchase 4,430 shares will vest in 12 substantially equal quarterly installments such that the stock option is fully vested on the third anniversary of the date of grant.
Documents
Issuer
GRI Bio, Inc.
CIK 0001824293
Entity typeother
Related Parties
1- filerCIK 0001398278
Filing Metadata
- Form type
- 4
- Filed
- Aug 26, 8:00 PM ET
- Accepted
- Aug 27, 8:24 AM ET
- Size
- 5.8 KB